Rachel Salisbury is a highly enthusiastic and passionate Biomedical Scientist currently serving as the Senior Clinical Director for Oncology at MSD. With a robust background in cancer immunotherapy and a PhD in human pancreatic development from the University of Manchester, Rachel brings a unique blend...
Rachel Salisbury is a highly enthusiastic and passionate Biomedical Scientist currently serving as the Senior Clinical Director for Oncology at MSD. With a robust background in cancer immunotherapy and a PhD in human pancreatic development from the University of Manchester, Rachel brings a unique blend of scientific rigor and clinical insight to her role. In her position within the European Clinical Development team for oncology, she is instrumental in driving key projects that focus on advancing innovative therapies for cancer patients.
Rachel's expertise encompasses a wide array of skills critical to the pharmaceutical industry, including clinical trials, clinical research, and medical writing. Her previous experience as a medical scientific liaison has equipped her with a deep understanding of the intricacies involved in bridging the gap between scientific research and clinical application. This experience is particularly valuable as she leads initiatives aimed at developing cutting-edge cancer immunotherapy treatments, leveraging her knowledge in pharmacology and the biology of the pancreas.
At MSD, Rachel is dedicated to fostering collaboration among multidisciplinary teams to ensure the successful execution of clinical trials. Her commitment to advancing oncology research is reflected in her strategic oversight of various projects that aim to improve patient outcomes and expand treatment options. With a genuine interest in science and research, Rachel Salisbury continues to be a driving force in the oncology landscape, committed to making a meaningful impact in the lives of patients battling cancer.
